Circulating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy

TitleCirculating myeloid-derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up-front with a risk-adapted strategy
Publication TypeJournal Article
Year of Publication2015
AuthorsRomano, A, Parrinello, NL, Vetro, C, Forte, S, Chiarenza, A, Figuera, A, Motta, G, Palumbo, GA, Ippolito, M, Consoli, U, Raimondo, FD
JournalBritish Journal of Haematology
Volume168
Pagination689-700
URLhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84922778516&partnerID=40&md5=9d4c43dbabb9c997cde2ef2e3d77a30c
DOI10.1111/bjh.13198